Contour NEXT

Clif Bars

Ascensia Diabetes Care, the makers of the CONTOUR® portfolio of blood glucose monitors, has empowered patients with diabetes to accurately track their blood sugar for more than 70 years.

CONTOUR® NEXT, the No. 1 pharmacist-recommended brand of blood glucose meters1, allow people with diabetes to manage their blood sugar levels easily throughout the day, eliminating the need for coding. In addition, CONTOUR® NEXT is the #1 test strip sold in Canada by salesΔ.

Ascensia continues to listen to the needs of people with diabetes to fuel innovative new technologies that consistently aim to improve diabetes management: clinical research has demonstrated that the use of the CONTOUR® NEXT ONE meter and app system can help reduce the chance of hypoglycemia4. Shop CONTOUR® NEXT products at London Drugs and start managing your health today!

Learn More
1 - 6 of 9
  • Ascensia Microlet Coloured Lancets - 100's Quick View

    ASCENSIA

    Ascensia Microlet Coloured Lancets - 100's

    • $9.29

    View Special Offers
  • Ascensia Microlet Coloured Lancets - 65506 - 200's Quick View

    ASCENSIA

    Ascensia Microlet Coloured Lancets - 65506 - 200's

    • $14.99

    View Special Offers
  • Contour Blood Glucose Test Strips - 50's Quick View

    ASCENSIA

    Contour Blood Glucose Test Strips - 50's

    • $46.99

    View Special Offers
  • Contour Next Blood Glucose Monitoring System Quick View

    ASCENSIA

    Contour Next Blood Glucose Monitoring System

    • $47.99

    View Special Offers
  • Contour Blood Glucose Test Strips - 100's Quick View

    ASCENSIA

    Contour Blood Glucose Test Strips - 100's

    • $77.99

    View Special Offers
  • Contour Next One Glucose Blood Monitoring System Quick View

    ASCENSIA

    Contour Next One Glucose Blood Monitoring System

    • $44.99

    View Special Offers
1 - 6 of 9

Managing Your Blood Glucose Levels with CONTOUR® NEXT Monitors.

People with type 1 or type 2 diabetes require consistent monitoring to help ensure that they maintain healthy blood glucose levels. They must react quickly when their blood sugar reaches levels below (hypoglycemia) or above (hyperglycemia) those recommended by their doctors, and may also need to track the timely administration of precise insulin doses. Additionally, results tracked over time allow people with diabetes to adjust their diet and exercise routines to maintain their blood glucose level on target.

If diabetes is not managed properly or left untreated, it can lead to several symptoms ranging from nerve damage, to increased risk of heart disease, and kidney damage5. Access to fast, accurate and easy to interpret blood glucose measurements is of prime importance to help avoid outcomes with profound health impacts.

The CONTOUR® NEXT ONE meter’s smartLIGHT feature ensures users receive feedback on their blood glucose results instantly. This technology takes the guesswork out of results by using a colour-coded flashing light system that shows green for results within target, red for readings that are below their target and yellow for results above target. Quick interpretation of blood glucose results helps guide decision making and may improve diabetes outcomes longer term4.

The CONTOUR® NEXT ONE monitor is Ascensia’s most accurate blood glucose measurement system to date, and helps patients test with confidence and make quick decisions to manage their diabetes effectively. The CONTOUR® NEXT ONE meter, and the results it supplies, goes beyond the minimum Canadian industry standard for blood glucose meters.2,3

Get the Most Out of Your Blood Glucose Monitor with CONTOUR® NEXT Test Strips, the #1 test strip in Canada (by sales)Δ, MICROLET® NEXT and MICROLET® Lancets

The CONTOUR® NEXT family of meters relies on specifically designed accessories and test strips to produce fast, accurate results with no coding required. Lancing devices and lancets are the first line of products necessary for people with diabetes to monitor their blood sugar.

MICROLET® lancets are silicone-coated to ensure a smooth, easy glide into the skin while ensuring enough blood is produced to fill the test strip. The MICROLET®NEXT lancing device allows individuals to choose from 5 different depth settings to minimize pain and make testing easy. MICROLET®NEXT lancing devices are included with all CONTOUR® NEXT meters.

CONTOUR® NEXT test strips are easily inserted into the meter to collect an adequate blood sample to test and produces reliable results even with a small blood sample. In addition, CONTOUR® NEXT test strips enable Second-Chance® sampling, which gives users more time to add blood to the same test strip. This means fewer test strips may be wasted during the process and reduced finger sticks.

Trust London Drugs and CONTOUR® NEXT products for Your Blood Sugar Monitoring Needs

Ascensia Diabetes Care is committed to providing the broadest collection of industry-leading products with its CONTOUR® NEXT portfolio so customers can meet all their blood glucose testing needs. Shop London Drugs’ variety of CONTOUR® NEXT meters and test strips to better manage your health today.

Disclaimers

Δ By sales. IQVIA (formerly IMS) market share of CONTOUR® NEXT test strip sales for the period Feb 2018-Feb 2019. Data on file.

1 Pharmacy Practice + Business and Profession Santé 2019 Survey on OTC Counselling and Recommendations

2 Current regulation based on Health Canada recognized ISO 15197:2013 standard requires results within ±15% range, specifically: ≥95% of results must fall within ±0.83 mmoL/L for blood glucose concentrations <5.55 mmoL/L and within ±15% for blood glucose concentrations ≥5.55 mmoL/L.

3 CONTOUR® NEXT ONE meter meets ±10% accuracy vs. laboratory method, specifically: 97.4% of results within ±10% for blood glucose concentrations ≥5.55 mmol/L, and 100% of results within ±0.56 mmol/L accuracy vs. laboratory method for blood glucose concentrations <5.55 mmol/L.

4 Stuhr A and Pardo S. Impact of Real-World Use of the CONTOUR® DIABETES App on Glycemic Control and Testing Frequency. Poster presented at the Diabetes Technology Meeting (DTM). November 8-10, 2018, North Bethesda, Maryland, USA. Real world evidence in 5,870 people with diabetes suggests that the use of the CONTOUR® DIABETES app for more than 180 days significantly decreased the likelihood of hypoglycemic events (<50mg/dL or <2.8 mmol/L) by 2.47 fold (in 654 people with diabetes), and decreased the likelihood of hyperglycemic events (>250mg/dL or <13.9 mmol/L) by 1.5 indicating improved blood glucose control.

5 https://www.diabetes.ca/managing-my-diabetes/preventing-complications